Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184014 · ClinicalTrials.gov registry record · Phase 4
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia
A Phase 4 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT01184014 is a Phase 4 study that has completed, run by HealthPartners Institute. The registered enrollment target is 72 participants.
The verdict
NCT01184014, a Phase 4 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.
Interventions
- DRUG NPH insulin plus Complete Insulin Orders
- DRUG Complete Insulin Orders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01184014
The ClinicalTrials.gov registry entry for NCT01184014 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NPH insulin plus Complete Insulin Orders is the first listed.
NCT01184014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01184014 about?
NCT01184014 is a clinical study titled "Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia". The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.
What is the current status of trial NCT01184014?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2010-08. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01184014?
The interventions under investigation include: NPH insulin plus Complete Insulin Orders (DRUG), Complete Insulin Orders (DRUG).
Who is sponsoring clinical trial NCT01184014?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.